People with the liver-wrecking hepatitis C virus who receive liver transplants are usually considered to have poor prospects because physicians expect the disease to attack the transplant within a few years. But researchers now report that these hepatitis C patients fare about as well over the decade following the procedure as do patients receiving liver transplants to ameliorate other conditions.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.